title: [Value of protocols of alternating chemotherapy versus melphalan-prednisone during the induction phase of stage III myelomas. Critical review].
authors.affiliation: Service de Rhumatologie, Hôpital Kremlin-Bicêtre.
authors.forename: B
authors.initials: B
authors.lastname: Paule
authors.forename: P
authors.initials: P
authors.lastname: Medicis
authors.forename: D
authors.initials: D
authors.lastname: Clerc
authors.forename: P
authors.initials: P
authors.lastname: Bennet
authors.forename: M
authors.initials: M
authors.lastname: Bisson
authors.forename: P
authors.initials: P
authors.lastname: Massias
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D011446:Prospective Studies; D011897:Random Allocation
chemical_list: D008558:Melphalan; D011241:Prednisone
vernacular_title: Intérêt des protocoles de chimiothérapies alternées versus melphalan-prednisone pendant la phase d'induction des myélomes stades III. Revue critique.